(Q43986558)

28 November 2017

title

Loperamide-induced enhancement of moxidectin availability in cattle (English)

1 reference

28 November 2017

Lifschitz A

1

1 reference

28 November 2017

Virkel G

2

1 reference

28 November 2017

Sallovitz J

3

1 reference

28 November 2017

Imperiale F

4

1 reference

28 November 2017

Pis A

5

1 reference

28 November 2017

Lanusse C

6

1 reference

28 November 2017

publication date

1 April 2002

1 reference

Journal of Veterinary Pharmacology and Therapeutics

28 November 2017

published in

1 reference

28 November 2017

volume

25

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

111-120

1 reference

The effect of level of feed intake on the pharmacokinetic disposition and efficacy of ivermectin in sheep.

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

Enhanced absorption of pour-on ivermectin formulation in rats by co-administration of the multidrug-resistant-reversing agent verapamil.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

Liquid chromatographic determination of ivermectin in animal plasma with trifluoroacetic anhydride and N-methylimidazole as the derivatization reagent

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

Decreased biotolerability for ivermectin and cyclosporin a in mice exposed to potent P‐glycoprotein inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

Pharmacokinetic disposition of benzimidazole drugs in the ruminant gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

Modifying the formulation or delivery mechanism to increase the activity of anthelmintic compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

The behaviour of doramectin in the gastrointestinal tract, its secretion in bile and pharmacokinetic disposition in the peripheral circulation after oral and intravenous administration to sheep.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

Relationship between pharmacological properties and clinical efficacy of ruminant anthelmintics

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

Comparative plasma disposition kinetics of ivermectin, moxidectin and doramectin in cattle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

Chemotherapy and delivery systems--helminths

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

Effects of the multidrug-resistance-reversing agents verapamil and CL 347,099 on the efficacy of ivermectin or moxidectin against unselected and drug-selected strains of Haemonchus contortus in jirds (Meriones unguiculatus).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

Reversal of P-glycoprotein-associated multidrug resistance by ivermectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

Fasting-induced changes to the pharmacokinetic behaviour of albendazole and its metabolites in calves.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

P-glycoproteins in nematodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

P-glycoprotein in the blood-brain barrier of mice influences the brain penetration and pharmacological activity of many drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

Structure and activity of avermectins and milbemycins in animal health

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

Genetic and biochemical evidence for a novel avermectin-sensitive chloride channel in Caenorhabditis elegans. Isolation and characterization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2885.2002.00396.X

10.1046/J.1365-2885.2002.00396.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference